Inventor
David Craig McGowan
Inventor
Brussels, BE
Overview
Patents· 49 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07BGeneral methods of organic chemistry1%
Y02ATechnologies for adaptation to climate change1%
C04BLime, magnesia1%
C07KPeptides1%
PatentTitleYear
11,117,887Aryl substituted pyrimidines for use in influenza virus infection202111,104,678Purine derivatives for the treatment of viral infections202111,091,467Modulators of THR-b and methods of use thereof202111,053,256Dihydropyranopyrimidines for the treatment of viral infections202110,865,193Pyridone derivatives for the treatment of viral infections and further diseases202010,822,347Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections202010,781,216Pyrrolo [3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases202010,780,089Pyrimidine derivatives for the treatment of viral infections202010,723,707Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections202010,647,6842-aminopyrimidine derivatives for the treatment of viral infections202010,626,108Heterocyclic indoles for use in influenza virus infection202010,611,755Aryl substituted pyrimidines for use in influenza virus infection202010,597,390Indoles for use in influenza virus infection202010,526,338Functionalized pentanoic acids for use influenza viral infections202010,457,638Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B201910,420,767Pyrimidine derivatives for the treatment of viral infections201910,385,054Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases201910,377,738Pyridone derivatives for the treatment of viral infections and further diseases201910,316,043Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections201910,280,167Purine derivatives for the treatment of viral infections201910,272,085Pyrimidine derivatives for the treatment of viral infections201910,259,7932-aminopyrimidine derivatives for the treatment of viral infections201910,259,814Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases201910,253,003Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections20199,932,346Pyrrolopyrimidines for use in influenza virus infection20189,663,474'Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections'20179,598,378'2-aminopyrimidine derivatives for the treatment of viral infections'20179,556,199'Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections'20179,556,176'Purine derivatives for the treatment of viral infections'20179,499,549'Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases'20169,365,582'Macrocyclic inhibitors of hepatitis C virus'20169,365,571'Piperidino-pyrimidine derivatives for the treatment of viral infections'20169,315,522'Antibacterial compounds'20169,284,304'Substituted pyrimidines as toll-like receptor modulators'20169,133,192'Piperidino-pyrimidine derivatives for the treatment of viral infections'20159,045,463'Phenyl ethynyl derivatives as hepatitis C virus inhibitors'20158,916,575'Quinazoline derivatives for the treatment of viral infections and further diseases'20148,637,663'Macrocyclic inhibitors of hepatitis C virus'20148,623,899'Bis-benzimidazole derivatives as hepatitis C virus inhibitors'20148,492,404'Bis-aryl amide compounds and methods of use'20138,436,036'Diaryl ethers'20138,383,584'HCV inhibiting macrocyclic phenylcarbamates'20138,178,557'Compounds and methods of use'20127,989,471'Macrocyclic inhibitors of hepatitis C virus'20117,776,869'Heteroaryl-substituted alkyne compounds and method of use'20107,754,717'Bis-aryl amide compounds and methods of use'20107,674,907'Furanopyridine derivatives and methods of use'20107,442,698'Substituted heterocyclic compounds and methods of use'20087,435,823'Compounds and methods of use'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2013Patents assigned to AMGEN INC (7)· patent assignee history
2008–2010Based in Woluwe-Saint-Pierre, BE· patent location history
2008Based in Arlington, MA, US· patent location history
2011–2021Based in Brussels, BE· patent location history
2013–2015Patents assigned to JANSSEN R & D IRELAND (6)· patent assignee history
2013–2015Patents assigned to RABOISSON PIERRE JEAN-MARIE BERNARD (6)· patent assignee history
2014–2019Based in Bruxelles, BE· patent location history
2015–2020Patents assigned to JANSSEN SCIENCES IRELAND UC (23)· patent assignee history
2019–2021Patents assigned to JANSSEN SCIENCES IRELAND UNLIMITED CO (11)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN SCIENCES IRELAND UC | 23 | 2015–2020 |
| JANSSEN SCIENCES IRELAND UNLIMITED CO | 11 | 2019–2021 |
| AMGEN INC | 7 | 2008–2013 |
| JANSSEN R & D IRELAND | 6 | 2013–2015 |
| RABOISSON PIERRE JEAN-MARIE BERNARD | 6 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brussels, BE | 42 | 2011–2021 |
| Woluwe-Saint-Pierre, BE | 4 | 2008–2010 |
| Bruxelles, BE | 2 | 2014–2019 |
| Arlington, Massachusetts, US | 1 | 2008 |